Elypta is a series a startup based in Sweden. 1 investor tracked.
Based in Sweden, Elypta is a startup founded in 2016. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. The company pioneers a metabolism-based liquid biopsy that measures the GAGome—system biomarkers of tumor metabolism—and uses machine learning to detect cancer signatures noninvasively.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.